Apex Ventures

What they fund

• Sector Focus — The firm concentrates exclusively on deep tech and scientific breakthroughs, with a specific strategic emphasis on the space sector, while also backing companies in AI, autonomous systems, energy transition, next-gen computing, and medical technologies.
• Stage & Ticket Size — They invest in early-stage companies, specifically from Seed to Series A, with an average initial ticket size ranging from €0.5m to €2.5m.
• Geographic Scope — The primary geographic focus is the DACH region and broader Europe, though they also engage with opportunities in North America.
• Investment Criteria — They target companies where defensible IP, technical depth, and market timing converge, seeking to back founders who can turn scientific insight into category-defining global companies.

Investment thesis

Apex Ventures invests in ambitious deep tech founders who leverage scientific insight and engineering excellence to build globally competitive companies. They provide focused capital for frontier innovation, targeting technology domains with the potential to reshape large global markets. The firm seeks exceptional problem solvers and founders best positioned to lead in high-barrier technical fields, valuing technical expertise and operational know-how.

Credibility: The thesis is derived directly from the firm's own website description of its investment focus and founder profile.

Value add

• Operational Support — The firm describes itself as a "venture builder" that provides focused capital and guidance to help founders build and scale globally.
• Strategic Guidance — Portfolio feedback indicates the firm contributes real guidance on strategy, organizational alignment, and execution, helping founders focus faster.
• Ecosystem Access — The team combines investment experience with access to European deep tech ecosystems, offering hands-on, thoughtful support to founders.

Portfolio focus

deep tech, scientific breakthrough, engineering excellence

Notable investments & exits

• Exits — HAAWK was acquired in 2024, representing a notable exit for the firm.
• Current Portfolio — Active investments include ATMOS Space, Cargo, HyperHeat, OroraTech, planqc, Quibim, CardiaTec, Contextflow, DeepSpin, Elucidate, enaDyne, enclaive, Farang, Fiber Elements, GEMESYS, Image Biopsy Lab, kiutra, Lendflo, Lyfegen, Mindpeak, Mobius Labs, NEOintralogistics, Novoic, OKAPI:Orbits, Permissionless Technologies, Phantasma Labs, Refined Diagnostics, Robeauté, Senisca, Sewts, Skycore Semiconductors, Solvemed, Spleenlab, Swaza, T3K Forensics, TriLite, UniSieve, Upfront Diagnostics, Vertus Energy, VitreaLab, VividQ, and Yuri.
• Alumni — Past investments or alumni include HAAWK, Lendflo, and Solvemed.

Strategic implications

Apex Ventures positions itself at the intersection of scientific discovery and commercial engineering, a niche that requires specialized founder vetting capabilities. The primary risk lies in the long development cycles typical of deep tech, which may strain a seed-stage fund's liquidity profile if follow-on capital is not secured. A shift in DACH government funding for deep tech would directly impact the firm's ability to co-invest and de-risk early-stage scientific ventures.

Where they could go further

The firm could strengthen its network by formalizing partnerships with European research institutes to source pre-seed scientific breakthroughs before they reach the market. Developing a clear follow-on fund strategy or LP commitments is critical to support deep tech companies through their longer capital-intensive development phases. Expanding the team with operators who have specific deep tech commercialization experience would enhance value-add for founders navigating regulatory and technical hurdles.